Correlation Between Rigel Pharmaceuticals and Amplia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Amplia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Amplia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Amplia Therapeutics Limited, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Amplia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Amplia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Amplia Therapeutics.
Diversification Opportunities for Rigel Pharmaceuticals and Amplia Therapeutics
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Rigel and Amplia is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Amplia Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amplia Therapeutics and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Amplia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amplia Therapeutics has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Amplia Therapeutics go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Amplia Therapeutics
Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 0.8 times more return on investment than Amplia Therapeutics. However, Rigel Pharmaceuticals is 1.25 times less risky than Amplia Therapeutics. It trades about 0.35 of its potential returns per unit of risk. Amplia Therapeutics Limited is currently generating about -0.23 per unit of risk. If you would invest 1,427 in Rigel Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 1,361 from holding Rigel Pharmaceuticals or generate 95.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Amplia Therapeutics Limited
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Amplia Therapeutics |
Rigel Pharmaceuticals and Amplia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Amplia Therapeutics
The main advantage of trading using opposite Rigel Pharmaceuticals and Amplia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Amplia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amplia Therapeutics will offset losses from the drop in Amplia Therapeutics' long position.| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
| Amplia Therapeutics vs. Rigel Pharmaceuticals | Amplia Therapeutics vs. Geron | Amplia Therapeutics vs. Verastem | Amplia Therapeutics vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |